Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis
- 3 January 2007
- journal article
- case report
- Published by Springer Nature in Clinical Rheumatology
- Vol. 26 (9) , 1585-1589
Abstract
We report on a patient of rheumatoid arthritis (RA) who sequentially developed an axillary mass and a fatal interstitial pneumonia during a 2-year course of methotrexate (MTX) therapy. Autopsy revealed a systemic lymph node involvement and the diagnosis of Epstein–Barr virus (EBV)-related lymphoproliferative disease (LPD) with the features of lymphomatoid granulomatosis was made. The lung tissue specimens revealed a typical diffuse alveolar damage (DAD), and small nodules consisting of atypical B lymphocytes showing positive staining for EBV were sparsely recognized only in basal lungs. This is the first report of a RA patient receiving MTX therapy sequentially developing MTX-associated lymphomatoid granulomatosis and DAD.Keywords
This publication has 19 references indexed in Scilit:
- Reactivation of Latent Epstein-Barr Virus by Methotrexate: A Potential Contributor to Methotrexate-Associated LymphomasJNCI: Journal of the National Cancer Institute, 2004
- Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti–tumor necrosis factor therapy in 18,572 patientsArthritis & Rheumatism, 2004
- Methotrexate-Induced Pulmonary LymphomaaChest, 2003
- Spontaneous remission of low‐grade B‐cell non‐Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literatureBritish Journal of Haematology, 2002
- Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in FranceBlood, 2002
- Clinical, laboratory, radiographic, and histopathologic features of methotrexate‐associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature reviewArthritis & Rheumatism, 1997
- Lymphoma in patients with rheumatoid arthritis: Association with the disease state or methotrexate treatment with the disease state or methotrexate treatmentSeminars in Arthritis and Rheumatism, 1997
- Pancytopenia secondary to methotrexate therapy in rheumatoid arthritisArthritis & Rheumatism, 1996
- Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: A retrospective studyThe American Journal of Medicine, 1995
- Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexateSeminars in Arthritis and Rheumatism, 1987